You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1826 to 1850 of about 5880
Next 25
07/06/2015
Epigenetic Driver of Glioblastoma Provides New Therapeutic Target
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.
07/05/2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
07/01/2015
Tocagen June 2015 Newsletter
06/27/2015
Problem with our websites and email
IBTA Newsletter
06/23/2015
FEATURED ON THE CERN-FOUNDATION WEB SITE, A BOOK ABOUT BRAIN TUMORS RASIES FUNDS FOR RESEARCH. WRITTEN BY A BRAIN TUMOR SRVIVIOR, A POINGNANT STORY OF A FAMILY STRUGGLING WITH BRAIN CANCER.
06/20/2015
New City Of Hope Clinical Trial Harnesses The Power Of The Immune System To Fight Brain Cancers
06/18/2015
Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics
06/13/2015
Free summer camp in NJ - Camp Jinka
06/05/2015
The Musella Foundation announced that it has awarded Tocagen Inc. a grant to support preclinical testing the compatibility of Tocagen’s therapy with 5-ALA or tumor treating fields.
06/04/2015
Blaze Bioscience Announces Open Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Children with Brain Cancer
06/03/2015
Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
Randomized Phase 2 ReACT Study of RINTEGA(R) in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Overall Survival and Emergence of Long-term Survival Benefit; Primary Endpoint of PFS6 Met
05/31/2015
Novocure Announces First Analysis of Full 700 Patient Dataset from Successful Newly Diagnosed GBM Phase III Trial
MUSELLA FOUNDATION AWARDS 6 BRAIN TUMOR RESEARCH GRANTS
05/28/2015
Novocure Announces Commercial Launch of Optune (the NovoTTF-100A System) in Japan
MN Brain Tumor 5K Breaks Previous Record for Attendance, Fundraising
Adding Bevacizumab (Avastin) Has No Impact on Quality of Life in Glioblastoma
Novocure Hosts First Glioblastoma-focused Hackathon to Develop New Support Tools for the GBM Brain Cancer Community
05/26/2015
IBTA e-News
Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation
05/25/2015
Do glioma patients derive any therapeutic benefit from taking a higher cumulative dose of temozolomide regimens?: a meta-analysis.
05/24/2015
Family Brings Awareness to Brain Tumors